title: What will allergen immunotherapy look like in the future?
authors: National Jewish Health, Denver, Colorado 80206, USA. nelsonh@njhealth.org
authors: Harold S
authors: HS
authors: Nelson
mesh_terms: D000485:Allergens / Q000009:adverse effects / Q000276:immunology*; D000818:Animals; D002986:Clinical Trials as Topic; D003888:Desensitization, Immunologic / Q000639:trends*; D004333:Drug Administration Routes; D005060:Europe; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy* / Q000276:immunology*; D007113:Immunity, Innate / Q000187:drug effects; D007073:Immunoglobulin E / Q000276:immunology; D010944:Plants / Q000276:immunology; D011058:Pollen / Q000009:adverse effects / Q000276:immunology*; D039981:Pyroglyphidae / Q000276:immunology; D058408:Th1-Th2 Balance / Q000187:drug effects; D014481:United States
chemical_list: D000485:Allergens; D007073:Immunoglobulin E